Wikisage, the free encyclopedia of the second generation, is digital heritage
Primidone: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
(→Links: Wikidata|Q420383) |
||
| Line 24: | Line 24: | ||
[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4242891/pdf/11606_2014_Article_2907.pdf Factors Associated with Ordering Laboratory Monitoring of High-Risk Medications] | [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4242891/pdf/11606_2014_Article_2907.pdf Factors Associated with Ordering Laboratory Monitoring of High-Risk Medications] | ||
{{Wikidata|Q420383}} | |||
==Notes== | ==Notes== | ||
<references/> | <references/> | ||
Revision as of 17:44, 25 November 2016
Primidone is an anticonvulsant that is metabolized to phenylethylmalonamide (PEMA) and phenobarbital[1], historical considered a prodrug of phenobarbital, nevertheless it is superior against tremor [2] [3] Chronic high-cumulative doses have shown to increase the fracture risk in a dose-dependent manner
ATC
antiepileptic drugs
Links
Interactions between antiepileptic drugs, and between antiepileptic drugs and other drugs
Factors Associated with Ordering Laboratory Monitoring of High-Risk Medications
Notes
- ↑ Practice Parameter:Therapies for essential tremor Report of the Quality Standards Subcommittee of the American Academy of Neurology
- ↑ Essential Tremor: What We Can Learn from Current Pharmacotherapy
- ↑ Molecular Mechanisms of Antiseizure Drug Activity at GABAA Receptors
- ↑ http://www.whocc.no/atc_ddd_index/?code=N03AA03
- ↑ Chronic high-cumulative doses have shown to increase the fracture risk in a dose-dependent manner